|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 193,100 KRW | +3.87% |
|
+1.85% | +96.04% |
| 2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
| 2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
On April 19, 2018, ALTEOGEN Inc. (KOSDAQ:A196170) closed transaction.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 125,400 KRW | -2.64% | -3.98% | 2.48B | ||
| 67,500 KRW | -1.32% | -3.30% | 2.8B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +96.04% | 7.51B | |
| -2.10% | 90.02B | |
| -1.18% | 39.15B | |
| -15.83% | 31.71B | |
| +62.61% | 26.47B | |
| -21.68% | 14.34B | |
| -8.73% | 12.89B | |
| -15.05% | 11.18B | |
| -45.69% | 10.97B | |
| +3.90% | 8.94B |
ALTEOGEN INC. 
